Search results for "ffpe challenges"

25

Refine your search

Explore by Field
Browse by Techniques

Search

Selected Filters:




VENTANA MMR RxDx Panel

Roche

The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab). 

0.0/5.0
|0 Reviews
  • Best New Clinical Assay or Kit of the Year

Industry News

Better crime scene testing

Forensic scientists at Flinders University present new data that sheds light on 'DNA shedding'

















Target Sufficiency

Inotiv

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

0.0/5.0
|0 Reviews
Request Pricing